DexCom

(NASDAQ) DXCM

Current Price$61.44

Market Cap$23.67B

Since IPO (2005)+1,990%

5 Year-36%

1 Year-13%

1 Month-2%

DexCom Financials at a Glance

Market Cap

$23.67B

Revenue (TTM)

$4.82B

Net Income (TTM)

$930.40M

EPS (TTM)

$2.34

P/E Ratio

26.25

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$61.44

Volume

10,563,037.088

Open

$60.98

Price

$61.44

Volume

10,563,037.088

Open

$60.98

Previous Close

$61.35

Daily Range

$59.70 - $62.85

52-Week Range

$54.11 - $89.98

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$61.44

Volume

10,563,037.088

Open

$60.98

Previous Close

$61.35

Daily Range

$59.70 - $62.85

52-Week Range

$54.11 - $89.98

DXCM News

diabetes CGM continuous glucose monitor blood

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

Prosper Junior BakinyApr 23, 2026

Page 1

DXCM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DexCom

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,100

CEO

Jacob S. Leach

Website

www.dexcom.com

Headquarters

San Diego, CA 92121, US

DXCM Financials

Key Financial Metrics (TTM)

Gross Margin

62%

Operating Margin

21%

Net Income Margin

19%

Return on Equity

36%

Return on Capital

23%

Return on Assets

14%

Earnings Yield

3.81%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$23.67B

Shares Outstanding

385.87M

Volume

10.56M

Avg. Volume

4.57M

Financials (TTM)

Gross Profit

$2.80B

Operating Income

$911.80M

EBITDA

$1.16B

Operating Cash Flow

$1.44B

Capital Expenditure

$363.50M

Free Cash Flow

$1.08B

Cash & ST Invst.

$2.00B

Total Debt

$1.39B

DexCom Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.19B

+15.0%

Gross Profit

$750.30M

+27.4%

Gross Margin

62.95%

N/A

Market Cap

$23.67B

N/A

Market Cap/Employee

$2.32M

N/A

Employees

10,200

N/A

Net Income

$199.50M

+89.3%

EBITDA

$322.40M

+66.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$1.08B

+817.0%

Accounts Receivable

$1.09B

-6.9%

Inventory

$693.60M

+28.9%

Long Term Debt

$1.38B

+1.8%

Short Term Debt

$20.50M

-98.3%

Return on Assets

14.03%

N/A

Return on Invested Capital

23.44%

N/A

Free Cash Flow

$449.00M

+363.8%

Operating Cash Flow

$525.60M

+186.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PHGKoninklijke Philips N.V.

PHGKoninklijke Philips N.V.$26.16-0.68%

WSTWest Pharmaceutical Services, Inc.

WSTWest Pharmaceutical Services, Inc.$300.68+1.04%

LHLabcorp Holdings Inc.

LHLabcorp Holdings Inc.$255.84-0.37%

STESTERIS plc

STESTERIS plc$214.40-1.14%

BIIBBiogen Inc.

BIIBBiogen Inc.$187.06-1.17%

WATWaters Corporation

WATWaters Corporation$307.12-0.68%

ZBHZimmer Biomet Holdings, Inc.

ZBHZimmer Biomet Holdings, Inc.$82.90+0.57%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About DXCM

What is the current price of DexCom?

DexCom is trading at $61.35 per share.

What is the 52-week range for DexCom?

Over the past 52 weeks, DexCom has traded between $54.11 and $89.98.

How much debt does DexCom have?

As of the most recent reporting period, DexCom reported total debt of $1.38B.

How much cash does DexCom have on hand?

DexCom reported $1.12B in cash and cash equivalents in its most recent financial results.

What is DexCom’s dividend yield?

DexCom does not currently have a dividend yield.

DexCom

DexCom Financials at a Glance

DXCM News

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

Best Internet of Things Stocks for 2026 and How to Invest

Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars

1 Growth Stock Down 19% to Buy Right Now

Top 2 Healthcare Stocks Every New Investor Should Know

DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?

1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street

Why DexCom Stock Is Crashing Today

DXCM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About DexCom

DXCM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

DexCom Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DXCM

What is the current price of DexCom?

What is the 52-week range for DexCom?

How much debt does DexCom have?

How much cash does DexCom have on hand?

What is DexCom’s dividend yield?

Premium Investing Services